NCT02434757 - Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions

Rheumatoid Arthritis

Interventions

DRUG

H.P. Acthar Gel

Acthar 40 U given SC daily for 7 days. Depending on the response and the Investigator,Acthar 40 U will continue Acthar 40 U 2x per week or increase to Acthar 80 U daily for 7 days followed by 2x per week

Trial Locations (1)

02720

RECRUITING

Phase III Clinical Research, Fall River